ITSCC
ITSCC
ITSCC

Basal cell carcinoma

Basal cell carcinoma is the second most common form of skin cancer in immunosuppressed transplant recipients. This is different than for the general population in which basal cell carcinoma is the most common. The risk for basal cell carcinoma is 10 times that of the general population.

It appears as a small, pink, pearly bump or patch that can ulcerate, bleed, or crust repeatedly. It occurs predominately on skin surfaces that have been exposed repeatedly to the sun such as the head and neck, but it may occur on any skin surface. It is slow growing and rarely spreads to other parts of the body. If left untreated, it can lead to extensive damage and destruction of the skin and underlying structures involved.

Treatment of basal cell carcinoma may consist of electrodesiccation and curettage, surgical excision, or Mohs surgery. Radiation may also be an optional treatment. Recommended treatment depends on the characteristics of the tumor and the patient.

Note: Please click on the thumbnails below to display a larger image.

Skin Cancer Skin Cancer
Skin Cancer Skin Cancer
Skin Cancer Skin Cancer


Updated on Tuesday, September 15th, 2009

ITSCC

Survey Request
We are looking at funding opportunities for a transplant skin cancer registry. A knowledge of which transplant centers are associated with our members and a rough idea of how many transplant patients are being followed would be helpful in this process. Please provide us with these brief details regarding your transplant practice. Click here to take survey


Board Nominations
We are accepting nominations to the 2012-2013 ITSCC Board of Directors
Self-nominations are welcomed!
Nominate


June 16-18, 2011
Skin Care in Organ Transplant Patients (SCOPE)
European Collaborative Group
Dundee, UK »


March 15, 2012
5:00 - 8:00 pm
ITSCC Annual Membership and Business Meeting
San Diego, CA  »


March 16, 2012
8:00 - 11:00 am
ITSCC Board of Directors Meeting
San Diego, CA »